|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lamivudine |
| Lopinavir + Ritonavir |
| Lopinavir + Ritonavir |
100 mg + 25 mg |
Tablet (heat stable)/ Tableta (termoestable) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x1 |
Ref: HA429
Ref: HA573 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
Ref: EMA Art 58 H-W-764-2
|
Ref: USFDA ANDA 09-0471 a 2
Ref: USFDA ANDA 09-1677 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Lopinavir + Ritonavir |
100 mg + 25 mg |
Tablet (heat stable)/ Tableta (termoestable) |
Bottle / Frasco |
120 tablets bottle / Frasco de 120 tabletas |
HDPE Bottle 120x1 / Frasco PEAD 120x1 |
Ref: HA429 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA ANDA 09-1677 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Lopinavir + Ritonavir |
40 mg + 10 mg |
Oral pellets (heat stable) / granulos en capsula (termoestable) |
Bottle / Frasco |
120 capsules bottle / Frasco de 120 capsulas |
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Nevirapine |
50 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x1 |
Ref: HA510 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA NDA 22-299 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Nevirapine |
10 mg/ml |
Oral suspension / Suspension oral |
Bottle / Frasco |
100 ml bottle / Frasco de 100 ml |
PET Bottle Amber 100ml / Frasco PET ambar 100 ml |
Ref: HA200 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es |
|
| Nevirapine |
10 mg/ml |
Oral suspension / Suspension oral |
Bottle / Frasco |
240 ml bottle / Frasco de 240 ml |
HDPE Bottle 240 ml / Frasco PEAD 240 ml |
|
|
|
Ref: USFDA ANDA 07-7702 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Raltegravir |
25 mg |
Tablet (chewable)/ Tableta (masticable) |
|
|
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
(3) See footnote / Ver nota al pie |
Upon request /
A peticion |
|
| Raltegravir |
100 mg |
Tablet (chewable)/ Tableta (masticable) |
|
|
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
(3) See footnote / Ver nota al pie |
Upon request /
A peticion |
|
| Ritonavir |
25 mg |
Tablet (heat stable)/ Tableta (termoestable) |
Bottle / Frasco |
30 tablets bottle / Frasco de 30 tabletas |
HDPE Bottle 30x1 / Frasco PEAD 30x1 |
Ref: HA621 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Ritonavir |
400 mg/5 ml |
Oral solution / Solucion oral |
Bottle / Frasco |
240 ml bottle / Frasco de 240 ml |
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Tenofovir |
200 mg |
Tablet / Tableta |
Bottle / Frasco |
30 tablets bottle / Frasco de 30 tabletas |
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Zidovudine |
60 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
|
|
|
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Zidovudine |
50mg/5ml (100ml) |
Oral solution / Solucion oral |
Bottle / Frasco |
100 ml bottle / Frasco de 100 ml |
HDPE Bottle 100mlx1 / Frasco PEAD 100mlx1 |
Ref: HA526 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Zidovudine |
50mg/5ml (100ml) |
Oral solution / Solucion oral |
Bottle / Frasco |
100 ml bottle / Frasco de 100 ml |
PET Bottle Amber Transparent + Plastic Syringe: 100x1 / Frasco PET ambar transparente + jeringa plastica 100x1 |
Ref: HA054 * |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Zidovudine |
50mg/5ml |
Oral solution / Solucion oral |
Bottle / Frasco |
240 ml bottle / Frasco de 240 ml |
HDPE Bottle 240ml/ Frasco PEAD 240ml |
Ref: HA486
Ref: HA526 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA ANDA 07-7268 1 |
HIV-AIDS / VIH-SIDA |
|
http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es |
|
| Zidovudine + Lamivudine |
60 mg + 30 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x1 |
Ref: HA572 * |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA NDA 20-2814 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Zidovudine + Lamivudine + Nevirapine |
60 mg+30 mg+50 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x2 |
Ref: HA433 *
Ref: HA557 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA NDA 20-3076 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| (1) Link to list of approved products is https://extranet.who.int/prequal/content/prequalified-lists/medicines. El Enlace a la lista de productos aprobados es https://extranet.who.int/prequal/content/prequalified-lists/medicines |
| (2) The price stated in the link (if available) is to be used as reference, since such price could be variable among different suppliers. El precio indicado en el enlace (si esta disponible) se utiliza como referencia, ya que dicho precio podria ser varia |
| (3) Procurement of this medicine through the Strategic Fund should be limited for use as third-line therapy in treatment-experienced HIV adults who failed second-line antiretroviral therapy. It is recommended patients receiving HIV/AIDS regimens including |
| (3) La adquisicion de este medicamento a traves del Fondo Estrategico debe ser limitada para su uso como tratamiento de tercera linea en adultos con VIH tratados previamente que reprobaron la terapia antirretroviral de segunda linea. Se recomienda que los |
| ANTIVIRALS / ANTIVIRALES |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pediatric Antiretrovirals / Antiretrovirales Pediatricos |
|
|
|
|
|
|
|
|
|
|
|
|
|
| International Nonproprietary Name (INN) / Denominacion Comun Internacional (DCI) |
Strength / Concentracion |
Dosage form / Forma farmaceutica |
Packing / Envase |
Packing size / Tamano del envase |
Packaging type / Tipo de empaque |
Prequalified by WHO / Precalificado por OMS |
Link to prequalification list / Enlace a la lista de precalificacion |
Approved by EMA or other agencies / Aprobado por EMA o por otras agencias (1) |
Approved by FDA or tentatively approved by FDA / Aprobado o tentativamente aprobado por FDA (1) |
Indication (s) / Indicacion (es) |
Notes / Notas |
Reference price / Precio de referencia (2) |
Purchase documents / Documentos para compra |
| Abacavir |
60 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x1
|
Ref: HA488
Ref: HA674 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Abacavir + Lamivudine |
60 mg + 30 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
120 tablets bottle / Frasco de 120 tabletas |
HDPE Bottle 120x1 / Frasco PEAD 120x1 |
Ref: HA518 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Abacavir + Lamivudine |
600 mg + 300 mg |
Tablet / Tableta |
Bottle / Frasco |
28 tablets bottle / Frasco de 28 tabletas |
HDPE Bottle 28x1 / Frasco PEAD 28x1 |
Ref: HA635 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Abacavir + Lamivudine |
600 mg + 300 mg |
Tablet / Tableta |
Bottle / Frasco |
30 tablets bottle / Frasco de 30 tabletas |
HDPE Bottle 30x1 / Frasco PEAD 30x1 |
Ref: HA635 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA ANDA 20-5412 2
Ref: USFDA ANDA 90-159 2
Ref: USFDA ANDA 09-1144 2
|
HIV-AIDS / VIH-SIDA |
|
http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es |
|
| Abacavir + Lamivudine |
120 mg + 60 mg |
Tablet (dispersible, scored) / Tableta (dispersable, ranurada) |
Bottle / Frasco |
60 tablets bottle / Frasco de 60 tabletas |
HDPE Bottle 60x1 / Frasco PEAD 60x1 |
Ref: HA662 |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Atazanavir |
100 mg |
Capsule / Capsula |
Bottle / Frasco |
60 capsules bottle / Frasco de 60 capsulas |
HDPE Bottle 60x1 / Frasco PEAD 60x1 |
|
|
|
Ref: USFDA ANDA 07-8785 a 2 |
HIV-AIDS / VIH-SIDA |
|
Upon request /
A peticion |
|
| Darunavir |
150 mg |
Tablet / Tableta |
Bottle / Frasco |
240 tablets bottle / Frasco de 240 tabletas |
HDPE Bottle 240x1 / Frasco PEAD 240x1 |
Ref: HA530 (a) |
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
|
HIV-AIDS / VIH-SIDA |
Age restriction > 3 years old / Restriccion de edad > 3 anos de edad. |
Upon request /
A peticion |
|
| Efavirenz |
200 mg |
Tablet (scored) / Tableta (ranurada) |
Bottle / Frasco |
90 tablets bottle / Frasco de 90 tabletas |
HDPE Bottle 90x1 / Frasco PEAD 90x1 |
Ref: HA389 *
Ref: HA428 (a)
|
https://extranet.who.int/prequal/content/prequalified-lists/medicines |
|
Ref: USFDA NDA 22-461 c 2 |
HIV-AIDS / VIH-SIDA |
|
http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es |
|
